Market Recap — July 16, 2026
Recap of insider activity, SEC filings, and market-moving news for July 16, 2026.
Last generated Sep 17, 2026, 3:35 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
SpringBig Hands Operating Business to Creditors in $12.5M Debt-for-Asset Swap; Shell Now Seeks Merger
Baker Hughes closes $210/share acquisition of Chart Industries; stock to be delisted
Eli Lilly to Acquire AtaiBeckley for $6.75/Share Cash Plus Up to $2.50 in CVRs
Eli Lilly to Acquire AtaiBeckley for $6.75/Share Cash + CVRs, ~$2.8B Upfront
Uber to Acquire Delivery Hero for $14.8B in Cash, Creating Global Delivery Giant
Medicare Finalizes Coverage for CareDx Transplant Tests, Shares Surge 35%
Jasper Therapeutics completes all-stock acquisition of Kira Pharmaceuticals, secures $132M PIPE, and grants $30M CVR to legacy shareholders
Braemar Closes $437.5M Three-Hotel Sale and Agrees to Sell Pier House Resort for $190M
Alcoa Slashes Alumina Guidance, Q2 Misses on Late-Quarter Aluminum Price Drop
LKCM-Led Group Lays Out $125M Equity Commitment and Voting Pact for DSGR Take-Private at $35/Share
CEO and CFO Resign Abruptly, Citing Change in Control; Interim Leadership Named
BioRestorative CEO and CFO Resign, Claiming $2.85M Severance; Lender-Appointed Director Steps In as CEO
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
SpringBig Hands Operating Business to Creditors in $12.5M Debt-for-Asset Swap; Shell Now Seeks Merger
Baker Hughes closes $210/share acquisition of Chart Industries; stock to be delisted
Eli Lilly to Acquire AtaiBeckley for $6.75/Share Cash + CVRs, ~$2.8B Upfront
Uber to Acquire Delivery Hero for $14.8B in Cash, Creating Global Delivery Giant
Medicare Finalizes Coverage for CareDx Transplant Tests, Shares Surge 35%
Jasper Therapeutics completes all-stock acquisition of Kira Pharmaceuticals, secures $132M PIPE, and grants $30M CVR to legacy shareholders
Braemar Closes $437.5M Three-Hotel Sale and Agrees to Sell Pier House Resort for $190M
Alcoa Slashes Alumina Guidance, Q2 Misses on Late-Quarter Aluminum Price Drop
CEO and CFO Resign Abruptly, Citing Change in Control; Interim Leadership Named
BioRestorative CEO and CFO Resign, Claiming $2.85M Severance; Lender-Appointed Director Steps In as CEO
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.